Mohammad Azab's Insider Trades & SAST Disclosures
Mohammad Azab's most recent trade in Lisata Therapeutics Inc was a trade of 15,789 Common Stock done . Disclosure was reported to the exchange on Jan. 9, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mohammad Azab.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lisata Therapeutics Inc | Mohammad Azab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 15,789 | 74,469 (0%) | 0% | 0 | Common Stock | |
| Durect Corp | Mohammad Azab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Sep 2024 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| Lisata Therapeutics Inc | Azab Mohammad | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 19,480 | 58,680 (0%) | 0% | 0 | Common Stock | |
| Xenon Pharmaceuticals Inc | Mohammad Azab | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 3,497 | 0 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Azab Mohammad | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.85 per share. | 19 Dec 2023 | 3,497 | 74,225 (0%) | 0% | 9.8 | 34,445 | Common Shares |
| Xenon Pharmaceuticals Inc | Mohammad Azab | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2023 | 823 | 0 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Azab Mohammad | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.85 per share. | 19 Dec 2023 | 823 | 70,728 (0%) | 0% | 9.9 | 8,107 | Common Shares |
| Durect Corp | Mohammad Azab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| Xenon Pharmaceuticals Inc | Mohammad Azab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2023 | 18,475 | 18,475 | - | - | Stock Option (Right to Buy) | |
| Lisata Therapeutics Inc | Mohammad Azab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 20,000 | 39,200 (0%) | 0% | 0 | Common Stock | |
| Xenon Pharmaceuticals Inc | Mohammad Azab | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.68 per share. | 12 Dec 2022 | 3,086 | 69,905 (0%) | 0% | 2.7 | 8,270 | Common Shares |
| Xenon Pharmaceuticals Inc | Mohammad Azab | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 3,086 | 0 | - | - | Stock Option (Right to Buy) | |
| Lisata Therapeutics Inc | Mohammad Azab | Director | Grant, award, or other acquisition of securities at price $ 6.25 per share. | 15 Sep 2022 | 19,200 | 19,200 (0%) | 0% | 6.3 | 120,000 | Common Stock |
| Xenon Pharmaceuticals Inc | Mohammad Azab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2022 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Durect Corp | Mohammad Azab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Durect Corp | Mohammad Azab | Director | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 24 May 2022 | 10,000 | 55,000 (0%) | 0% | 0.4 | 3,889 | Common Stock |
| Durect Corp | Mohammad Azab | Director | Purchase of securities on an exchange or from another person at price $ 0.38 per share. | 24 May 2022 | 5,000 | 45,000 (0%) | 0% | 0.4 | 1,895 | Common Stock |
| Durect Corp | Mohammad Azab | Director | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 24 May 2022 | 5,000 | 35,000 (0%) | 0% | 0.4 | 1,963 | Common Stock |
| Durect Corp | Mohammad Azab | Director | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 24 May 2022 | 5,000 | 40,000 (0%) | 0% | 0.4 | 1,942 | Common Stock |
| Durect Corp | Mohammad Azab | Director | Purchase of securities on an exchange or from another person at price $ 0.39 per share. | 24 May 2022 | 5,000 | 60,000 (0%) | 0% | 0.4 | 1,950 | Common Stock |
| Durect Corp | Mohammad Azab | Director | Purchase of securities on an exchange or from another person at price $ 0.38 per share. | 16 May 2022 | 10,000 | 10,000 (0%) | 0% | 0.4 | 3,767 | Common Stock |
| Durect Corp | Mohammad Azab | Director | Purchase of securities on an exchange or from another person at price $ 0.42 per share. | 16 May 2022 | 9,300 | 19,300 (0%) | 0% | 0.4 | 3,899 | Common Stock |
| Durect Corp | Mohammad Azab | Director | Purchase of securities on an exchange or from another person at price $ 0.42 per share. | 16 May 2022 | 8,900 | 28,200 (0%) | 0% | 0.4 | 3,749 | Common Stock |
| Durect Corp | Mohammad Azab | Director | Purchase of securities on an exchange or from another person at price $ 0.42 per share. | 16 May 2022 | 1,800 | 30,000 (0%) | 0% | 0.4 | 758 | Common Stock |
| Durect Corp | Mohammad Azab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 27,500 | 27,500 | - | - | Stock Option (right to buy) | |
| Xenon Pharmaceuticals Inc | Mohammad Azab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Durect Corp | Mohammad Azab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 70,000 | 70,000 | - | - | Stock Option (right to buy) | |
| Xenon Pharmaceuticals Inc | Mohammad Azab | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2020 | 3,086 | 0 | - | - | Stock Option (Right to Buy) | |
| Xenon Pharmaceuticals Inc | Mohammad Azab | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.76 per share. | 15 Dec 2020 | 3,086 | 63,733 (0%) | 0% | 3.8 | 11,603 | Common Shares |
| Xenon Pharmaceuticals Inc | Mohammad Azab | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges